| |
Papers
published by Expression Analysis
Shi, L, Reid, LH, Jones, WD, et al. 2006. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 24(9):1151-1161.
Shippy, R, Fulmer-Smentak, S, Jensen, RV, Jones, WD, et al. 2006. Using RNA sample titrations to assess microarray platform performace and normalization techniques. Nat. Biotechnol., 24(9):1123-1131.
Reid, LH and Warrington, JA. 2006. A note on nomenclature. Nat. Biotechnol., 24(9):1103.
Ginsburg,
G and Angrist, M. 2006. The
future may be closer than you think: a response
from the Personalized Medicine Coalition to the
Royal Society's report on personalized medicine. Personalized Medicine, 3(2):119-123.
Goralski, T and Pusztai, L. 2006. Expression Profile Predicts Best Preoperative Chemotherapy Regimen for Individual Breast Cancer Patients. Affymetrix Microarray Bulletin, 2(2):4-8.
External RNA Controls Consortium (L Reid corresponding author). 2005. Proposed methods for testing and selecting ERCC External RNA Controls. BMC Genomics, 6:150.
McPhail,
S and Goralski, T. 2005. Overcoming Challenges of Using Blood Samples with Gene Expression
Microarrays to Advance Patient Stratification
in Clinical Trials.
Drug Discovery Today, 10(22):1485-1487. Visit
Drug Discovery Today
Reid, LH, Cohn, R, Goralski, T, and McPhail, S. 2005. Mock Regulatory Submissions Using Microarray Data. IVD Technology, 11(4):24-29.
Casey, S. 2005. Microarrays on the Spot Year in Review. Pharmaceutical Discovery, 5(9).
Monforte, J. 2005. The Importance of Introducing Gene Expression Analysis Into Pharmacological Development. Pharmaceutical Discovery, 5(7).
Goralski, T. 2005. Moving Gene Expression Microarray Data to the Clinic - An Analytical Requirements Perspective. Pharmaceutical Discovery, 5(6).
Jones, W. 2005. Microarray
Probes That Mask Differential Expression.
Pharmaceutical Discovery, 5(5).
Brooks, A. 2005. Microarray Data Comparability:An Array of Opportunity? Pharmaceutical Discovery, 5(4).
Reid, LH. 2005. The
Value Of A Proficiency Testing Program To Monitor
Performance In Microarray Laboratories.
Pharmaceutical Discovery, 5(3):20-25.
Parker, J. 2005. Getting
More Out of Public Microarray Data.
Pharmaceutical Discovery, 5(2).
McPhail, S. 2005. Harnessing
the Potential of Genomic Data. Pharmaceutical Discovery, 5(1).
Papers
published using data generated at Expression Analysis
Seo, D, Wang, T, Dressman,
H, Herderick, EE, Iversen, ES, Dong, C, Vata,
K, Milano, CA, Rigat, F, Pittman, J, Nevins,
JR, West, M, and Goldschmidt-Clermont, PJ. 2004. Gene
expression phenotypes of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular
Biology, 24(10):1922-1927.
Tadashi, O and Hogan, BL. 2004.
Hyperactive
Wnt signaling changes the developmental potential
of embryonic lung endoderm.
Journal of Biology, 3:11.
Pittman, J, Huang, E, Dressman,
H, Horng, CF, Cheng, SH, Tsou, MH, Chin, CM,
Bild, A, Iversen, ES, Huang, A, Nevins, JR
and West, M. 2004. Integrated
modeling of clinical and gene expression information
for personalized prediction of disease outcomes. PNAS, 101(22):8431-8436.
Maddala, R, Deng, PF, Costello,
JM, Wawrousek, EF, Zigler, JS, Rao, VP. 2004. Impaired cytoskeletal organization and membrane
integrity in lens fibers of a Rho GTPase functional
knockout transgenic mouse. Lab
Investigation, 84(6):679-692.
Berchuck, A, Iversen, ES,
Lancaster, JM, Dressman, HK, West, M, Nevins,
JR and Marks, JR. 2004. Prediction
of optimal versus suboptimal cytoreduction of
advanced stage serous ovarian cancer using microarrays.
American Journal of Obstetrics and Gynecology, 190:910-923.
Yao, WD, Gainetdinov, RR,
Arbuckle, MI, Sotnikova, TD, Cyr, M, Beaulieu,
JM, Torres, GE, Grant, SG, Caron, MG. 2004. Identification
of PSD-95 as a regulator of dopamine-mediated
synaptic and behavioral plasticity. Neuron, 41(4):625-638.
Hashimoto, T, Lawton, MT,
Yang, G-Y, Wen, G, Chaly, T Jr., Stewart, CL,
Dressman, HK, Barbaro, NM, Marchuck, DA, Young,
WL. 2004. Gene
Microarray Analysis of Human Brain Arteriovenous
Malformations. Neurosurgery, 54:410-423.
Huang, ES, Black, EP,
Dressman, H, West, M and Nevins, JR. 2003.
Gene
expression phenotypes of oncogenic signaling pathways. Cell Cycle, 2(5):415-417.
Ellis, MJ, Rosen, E, Dressman,
H and Marks, J. 2003. Neoadjuvant
comparisons of aromatase inhibitors and tamoxifen:
pretreatment determinants of response and on-treatment
effect. J Steroid Biochem
Mol Biol., 86:301-307.
Nevins, JR., Huang, ES,
Huang, AT, Dressman, H, Pittman, J, and West,
M. 2003. Towards
integrated clinico-genomic models for personalized
medicine: combining gene expression signatures
and clinical factors in breast cancer outcomes
prediction. Human Moecluar
Genetics, 12 Suppl 2:R153-7.
Black, E P, Huang, E, Dressman,
H, Ishida, S, West, M, and Nevins, JR. 2003. Distinct gene expression
phenotypes of cells lacking Rb and Rb family members.Cancer Research, 63:3716-3723.
Oliver, TG, Grasfeder, LL,
Carrol, AL, Kaiser, C, Gillingham, CL, Lin,
SM, Wickramasinghe, R, Scott, MP, Wechsler-Reya,
RJ. 2003. Transcriptional
profiling of the Sonic hedgehog response: a critical
role for N-myc in proliferation of neuronal precursors. PNAS, 100(12):7331-7336.
Huang, E, Ishida, S, Pittman,
J, Dressman, H, Bild, A, Kloos, M, D'Amico,
M, Pestell, RG, West, M and Nevins, JR. 2003. Gene
expression phenotypic models that predict the
activity of oncogenic pathways. Nature Genet., 34:226-230.
Huang, E, Cheng, SH, Dressman,
H, Pittman, J, Tsou, M-H, Horng, C-F, Bild,
A, Iversen, ES, Liao, M, Chen, C-M, West,
M, Nevins, JR and Huang, AT. 2003. Gene
expression predictors of breast cancer outcomes. Lancet, 361(55):1590-1596.
|
|
